US equities
|
MU
$1,030.16
▼-0.55%
NVDA
$229.75
▼-0.32%
TSLA
$382.39
▲+1.97%
SPCX
$161.53
▲+0.60%
AAPL
$334.79
▼-1.65%
SNDK
$1,602.45
▼-0.44%
AMD
$610.49
▼-1.64%
AMZN
$260.06
▲+2.36%
MU
$1,030.16
▼-0.55%
NVDA
$229.75
▼-0.32%
TSLA
$382.39
▲+1.97%
SPCX
$161.53
▲+0.60%
AAPL
$334.79
▼-1.65%
SNDK
$1,602.45
▼-0.44%
AMD
$610.49
▼-1.64%
AMZN
$260.06
▲+2.36%
FinancialContent
Sign in
Markets
Overview
News
World markets
Treasuries
Currencies
Commodities
Economy
Stocks
Overview
Most active
Gainers
Losers
Largest companies
52-week gainers
52-week losers
ETFs
Overview
Popular funds
Most active
Gainers
Losers
News
Research
Search
Sectors
Coeptis Therapeutics Holdings, Inc. - Common Stock
(NQ:
COEP
)
16.40
UNCHANGED
Last Price
Updated: 4:00 PM EDT, Apr 24, 2026
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Press Releases about Coeptis Therapeutics Holdings, Inc. - Common Stock
< Previous
1
2
Next >
Coeptis Announces Approval of Z Squared Inc.’s Nasdaq Listing Application
April 07, 2026
From
Coeptis Therapeutics
Via
GlobeNewswire
Vanderbilt Report: Coeptis / Z Squared Merger Enters Final Stretch - Closing Imminent as Institutional Tailwinds Build
March 09, 2026
Via
ACCESS Newswire
Coeptis Receives Shareholder Approval Towards Z Squared Merger
February 05, 2026
Shareholder Approval Clears a Key Condition to Close
From
Coeptis Therapeutics
Via
GlobeNewswire
Coeptis Therapeutics S-4 Declared Effective by SEC, Proxy Mailing Begins in Anticipation of the Merger Transaction with Z Squared
January 06, 2026
~ Annual/Special Meeting of Shareholders to be Held on January 30, 2026 ~
From
Coeptis Therapeutics
Via
GlobeNewswire
Biotech Bright Spots: Coeptis Therapeutics (COEP) And 3 Hidden Treasures
February 21, 2024
Via
Get News
Three Biotech Companies Redefining Value Creation Through Dual Strategies
October 14, 2025
Via
ACCESS Newswire
SHAREHOLDER RIGHTS ALERT: Halper Sadeh LLC Investigates BFIN, COEP, ARIS, CIO on Behalf of Shareholders
October 07, 2025
From
Halper Sadeh LLC
Via
GlobeNewswire
Coeptis Anchors $800M Valuation in Dual-Sector Strategy; Vanderbilt Report Publishes Coverage
October 01, 2025
Via
ACCESS Newswire
Coeptis (COEP) Extinguishes Convertible Note with YA II PN, Ltd
July 22, 2025
From
Coeptis Therapeutics
Via
GlobeNewswire
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates SAGE, COEP, AVDX on Behalf of Shareholders
July 05, 2025
From
Halper Sadeh LLC
Via
GlobeNewswire
Coeptis (COEP) Announces Filing of Registration Statement on Form S-4 with SEC in Connection with Proposed Transaction with Z Squared
June 26, 2025
From
Coeptis Therapeutics
Via
GlobeNewswire
Monarch Therapeutics and SNAP Biosciences, Inc., a Subsidiary of Coeptis Therapeutics Holdings Inc., Enter Licensing Agreement to Bolster SNAP-CAR NK Cell Therapy in Oncology
May 28, 2025
From
Coeptis Therapeutics
Via
GlobeNewswire
BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Skechers U.S.A., Inc. (NYSE - SKX), BioSig Technologies, Inc. (Nasdaq – BSGM), Coeptis Therapeutics Holdings, Inc. (Nasdaq – COEP), Pacific Premier Bancorp, Inc.
May 05, 2025
From
Brodsky & Smith LLC
Via
GlobeNewswire
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates COEP and PPBI on Behalf of Shareholders
May 01, 2025
From
Halper Sadeh LLC
Via
GlobeNewswire
BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Kronos Bio, Inc. (Nasdaq - KRON), Regulus Therapeutics Inc. (Nasdaq – RGLS), Coeptis Therapeutics Holdings, Inc. (Nasdaq – COEP), Pacific Premier Bancorp, Inc.
May 01, 2025
From
Brodsky & Smith LLC
Via
GlobeNewswire
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates OPTN, COEP, SWTX, CKPT on Behalf of Shareholders
April 30, 2025
From
Halper Sadeh LLC
Via
GlobeNewswire
COEP Stock Alert: Halper Sadeh LLC Is Investigating Whether the Merger of Coeptis Therapeutics Holdings, Inc. Is Fair to Shareholders
April 25, 2025
From
Halper Sadeh LLC
Via
Business Wire
COEPTIS (COEP) Expands Global Footprint with Strategic India Tech Hub
April 22, 2025
Via
AB Newswire
Topics
Artificial Intelligence
Intellectual Property
Coeptis Therapeutics, Inc. and Z Squared Inc. Announce Merger Agreement
April 25, 2025
Aim to create the largest publicly-traded, Dogecoin-focused mining company in the world Coeptis to spin out biopharmaceutical operations
From
Coeptis Therapeutics
Via
GlobeNewswire
COEPTIS Partners with NexGenAI Solutions Group to Launch New AI Co-Working Hub in India, Driving Global Innovation in Technology
April 17, 2025
Strategic Collaboration Enhances Access to Cutting-Edge AI, Blockchain Solutions, Biopharma & Defense Technologies
From
Coeptis Therapeutics
Via
GlobeNewswire
Coeptis (NASDAQ: COEP) Accelerates Growth with Strategic Partnerships and Innovation
March 17, 2025
Via
AB Newswire
Topics
Artificial Intelligence
Coeptis Inc. (COEP) Expands Cancer Immunotherapy Portfolio with Exclusive GEAR Cell Therapy License
March 14, 2025
Via
AB Newswire
Coeptis Therapeutics Secures Worldwide Development and Commercialization Rights to Next-Generation GEAR™ Cell Therapy Platform Strengthening its High-Impact Precision Immuno-Oncology Pipeline
March 11, 2025
From
Coeptis Therapeutics
Via
GlobeNewswire
COEPTIS’ NexGenAI Affiliates Partners with NUBURU Network to Drive Innovation in AI and Robotics as Part of its Transformation Plan
March 07, 2025
Leveraging Advanced AI and Robotics to Revolutionize Marketing Strategies in Defense and Security Sectors
From
Coeptis Therapeutics
Via
GlobeNewswire
COEPTIS’ NexGenAI Partners with Arketyp Valu to Revolutionize Digital Engagement on the Verus Network
February 20, 2025
The Strategic Collaboration Integrates Cutting-Edge Marketing Tools into the ValuSocial Platform, Leveraging the Robust Capabilities of Verus Coin and Blockchain Technology
From
Coeptis Therapeutics
Via
GlobeNewswire
COEPTIS NexGenAI Affiliates Network & MarketLeverage Announce Strategic Partnership to Revolutionize AI-Powered Affiliate Marketing
February 20, 2025
This partnership gives COEPTIS access to AI-driven campaign management, predictive analytics, and automated outreach capabilities with MarketLeverage’s 5,500 advertisers and 55,000 publishers, creating...
From
Coeptis Therapeutics
Via
GlobeNewswire
COEPTIS NexGenAI Affiliates Network & MarketLeverage Announce Strategic Partnership to Revolutionize AI-Powered Affiliate Marketing
February 19, 2025
This partnership gives COEPTIS access to AI-driven campaign management, predictive analytics, and automated outreach capabilities with MarketLeverage’s 5,500 advertisers and 55,000 publishers, creating...
From
Coeptis Therapeutics
Via
GlobeNewswire
Coeptis Therapeutics (Nasdaq: COEP) Emerges as a Biopharma Innovator Leveraging AI-Driven Marketing
January 17, 2025
Via
AB Newswire
Topics
Artificial Intelligence
Biotech Innovation: Coeptis Therapeutics (COEP) And 3 Companies Changing The Game
February 21, 2024
Via
Get News
These are the 4 hottest stocks insiders bought in January
January 29, 2024
Insiders are buying these stocks, but not all are good buys for investors or bullish traders; avoid stocks with high short interest, no revenue, and no earnings
Via
MarketBeat
< Previous
1
2
Next >
